Sanguina

Sanguina Secures Investment from Georgia Innovation Investor Syndicate

Sanguina

2025 in Review: How Sanguina Is Transforming Blood Health Access Worldwide

Ruby

Meet Ruby - A New Era of Blood Health

NIH

Sanguina Wins NIH Grand Prize: Making Maternal Health Monitoring More...

NIH

Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge

AnemoCheck

Sanguina collaborators publish new findings

FDA

Sanguina announces U.S. FDA-Clearance for AnemoCheck Home

Sanguina

A Letter From Our CEO, Erika Tyburski

Sanguina

A Message From Our CEO, Erika Tyburski